The Team

Dr. Bavry serves as the CEO of Lucent Line, a Professor of Internal Medicine at UT Southwestern Medical Center, and as the Director of the Structural Heart Program at William P. Clements Jr. University Hospital. Trained at the University of Arizona and the Cleveland Clinic, his expertise spans cardiovascular medicine and interventional cardiology. He contributes significantly to the field as an Associate Editor of ACC.org Clinical Trials and is a member of the editorial board of Clinical Cardiology. Dr. Bavry's leadership and academic experience drives Lucent Line's innovative initiatives in cardiovascular diagnostics tools.

 Partnering with Huck Medical offers significant advantages for Lucent Line, especially in the development and commercialization of our innovative Bavry Catheter. Huck Medical's expertise is in medical device prototyping, regulatory navigation, and quality management systems is particularly beneficial. Their FDA-registered facility, capable of handling both small and large-scale manufacturing, aligns well with the needs for producing the Bavry Catheter. This partnership not only accelerates the development and testing phases but also ensures adherence to stringent regulatory standards, ultimately facilitating a smoother pathway to market for Lucent Line’s cutting-edge cardiac diagnostic tools.